 |
 |
| Richter, James |
|
| Ulrich, Lynn |
|
| Lombardi, George |
|
| Rurka, Maureen |
|
| Essig, Christopher |
|
| Warner, Kevin |
|
| Ferranti, William |
|
| Maglione, Anne |
|
| Shin, Howard |
|
| Bess, Michael |
|
| Maxfield, Samantha |
|
| Hicks, Scotia |
|
| Alarcon Duvanel, Vanessa |
|
| Bogad, Melissa |
|
| Kostytska, Maria |
|
| Lehman, Heather |
|
|
 |
|
| Intellectual Property |
|
| Patent Litigation |
|
| Litigation |
|
|
|
|
| In Re 318 Patent Infringement Litigation |
|
Teva North America
|
|
|
|
| We obtained a trial win for Barr Labs in an Abbreviated New Drug Application case in which Barr challenged the validity of a patent covering a method of treating Alzheimer’s disease using a drug called Galantamine, which is sold by Janssen under the trade name Razadyne IR®. This decision enables Barr to compete for a share of what is currently a $130 million market. |
|
|
Select A Region
Search for an attorney.
